Cargando…
MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity
MLL3 is a histone H3K4 methyltransferase that is frequently mutated in cancer, but the underlying molecular mechanisms remain elusive. Here, we found that MLL3 depletion by CRISPR/sgRNA significantly enhanced cell migration, but did not elevate the proliferation rate of cancer cells. Through RNA-Seq...
Autores principales: | Zheng, Jun-Yi, Wang, Chen-Yu, Gao, Chuan, Xiao, Qiong, Huang, Cheng-Wei, Wu, Min, Li, Lian-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024252/ https://www.ncbi.nlm.nih.gov/pubmed/33824309 http://dx.doi.org/10.1038/s41419-021-03647-2 |
Ejemplares similares
-
Immunohistochemical Analysis of the Expression of Adhesion Proteins: TNS1, TNS2 and TNS3 in Correlation with Clinicopathological Parameters in Gastric Cancer
por: Nizioł, Marcin, et al.
Publicado: (2021) -
Abnormal TNS3 gene methylation in patients with congenital scoliosis
por: Wu, YuanTao, et al.
Publicado: (2022) -
Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
por: Lin, Xiang, et al.
Publicado: (2023) -
Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma
por: Shi, Yang, et al.
Publicado: (2021) -
MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis
por: Lai, Binbin, et al.
Publicado: (2017)